Market Research Logo

Natera Inc (NTRA) - Product Pipeline Analysis, 2018 Update

Summary

Natera Inc (Natera), formerly Gene Security Network Inc is a genetic testing and diagnostics company that develops and commercializes non-invasive methods for DNA analysis. The company offers products such as panorama prenatal testing, pre-implantation genetic testing, miscarriage testing, genetic carrier screening and paternity testing. Its pre-implantation genetic testing includes translocation testing, aneuploidy screening, and single gene testing. Natera offers constellation, a cloud-based software product that allows laboratory customers to gain access through the cloud to the company’s algorithms and bioinformatics in order to validate and launch tests. The company also undertakes clinical trial of several genetic materials. Natera is headquartered in San Carlos, California, the US.

This report is a source for data, analysis, and actionable intelligence on the company’s portfolio of pipeline products. The report provides key information about the company, its major products and brands.

The report enhances decision making capabilities and help to create effective counter strategies to gain competitive advantage.

Scope:

  • The report reviews detailed company profile with information on business description, key company facts, major products and services, key competitors, key employees, locations and subsidiaries and recent developments
  • The report analyzes all pipeline products in development for the company Natera Inc
  • The report provides pipeline analysis on all pipeline products of the company (by equipment type, by indication, by development stage, and by trial status)
  • The report covers detailed information on each pipeline product with information on pipeline territory, stage of development, device class, regulatory path, indication(s), application(s) and estimated launch date
  • The report provides detailed description of products in development, technical specification and functions
  • The report also covers ongoing clinical trials (wherever applicable) with information on trial name, trial objective, sponsor, trial design , trial status and phase, estimated start and end date.
Reasons to Buy:
  • Develop business strategies by understanding the trends and developments driving the medical devices pipeline and technology landscape
  • Design and develop your product development, marketing and sales strategies by understanding the competitor portfolio
  • To formulate effective Research & Development strategies
  • Develop market-entry and market expansion strategies
  • Exploit in-licensing and out-licensing opportunities by identifying products, most likely to ensure a robust return
  • Plan mergers and acquisitions effectively by identifying key players of the most promising pipeline
  • Identify emerging players with potentially strong product portfolio and create effective counter-strategies to gain competitive advantage
  • Develop competition strategies by identifying the status and likely launch of the competitors’ pipeline products through review of the clinical trials, stage and of development, etc
  • Identify, understand and capitalize the next high-value products that your competitor would add in its portfolio
Note: Some sections may be missing if data is unavailable for the company


Natera Inc Company Overview
Natera Inc Company Snapshot
Natera Inc Pipeline Products and Ongoing Clinical Trials Overview
Natera Inc – Pipeline Analysis Overview
Natera Inc - Key Facts
Natera Inc - Major Products and Services
Natera Inc Pipeline Products by Development Stage
Natera Inc Ongoing Clinical Trials by Trial Status
Natera Inc Pipeline Products Overview
Anora Natera Miscarriage POC Test
Anora Natera Miscarriage POC Test Product Overview
Constellation
Constellation Product Overview
dd-cfDNA Assay - Kidney Transplant Rejection
dd-cfDNA Assay - Kidney Transplant Rejection Product Overview
Horizon Carrier Screen Test
Horizon Carrier Screen Test Product Overview
Non-Invasive DNA Based Test - Breast Cancer
Non-Invasive DNA Based Test - Breast Cancer Product Overview
Non-Invasive DNA Based Test - Lung Cancer
Non-Invasive DNA Based Test - Lung Cancer Product Overview
Non-Invasive DNA Based Test - Ovarian Cancer
Non-Invasive DNA Based Test - Ovarian Cancer Product Overview
Non-invasive DNA Based Test - Therapeutic Monitoring
Non-invasive DNA Based Test - Therapeutic Monitoring Product Overview
Panorama Non-Invasive Prenatal Expanded Test
Panorama Non-Invasive Prenatal Expanded Test Product Overview
Panorama Non-Invasive Prenatal Expanded Test Clinical Trial
Signatera - Breast Cancer
Signatera - Breast Cancer Product Overview
Signatera - Colorectal Cancer
Signatera - Colorectal Cancer Product Overview
Spectrum PGD Test
Spectrum PGD Test Product Overview
Spectrum PGS Test
Spectrum PGS Test Product Overview
Vistara Non-Invasive Prenatal Test
Vistara Non-Invasive Prenatal Test Product Overview
Vistara Non-Invasive Prenatal Test Clinical Trial
Natera Inc - Key Competitors
Natera Inc - Key Employees
Natera Inc - Locations And Subsidiaries
Head Office
Other Locations & Subsidiaries
Recent Developments
Natera Inc, Recent Developments
Jun 21, 2018: Natera Develops Powerful Kidney Transplant Rejection Biomarker
Jun 19, 2018: Natera and Institut Jules Bordet partner on breast cancer research
Jun 13, 2018: Natera Announces New Clinical Utility Data and Issuance of CPT Code for NIPT in Twin Pregnancies
May 09, 2018: ECRI Institute Reveals Important Differences in Prenatal Genetic Tests
May 08, 2018: Natera Reports First Quarter 2018 Financial Results
Apr 13, 2018: Natera to Present Successful Results at AACR from Bladder and Colon Cancer Studies
Apr 09, 2018: Natera Appoints Paul R. Billings, M.D., Ph.D., as Chief Medical Officer
Mar 13, 2018: Natera Announces Fourth Quarter And Fiscal Year 2017 Financial Results
Mar 05, 2018: Natera's Genetic Tests Now Fully Integrated into Yale New Haven Health's Epic EMR System
Jan 29, 2018: Natera To Feature Expanded Panorama Non-Invasive Prenatal Test, Now Validated for Twin Pregnancies, at SMFM Annual Meeting
Appendix
Methodology
About GlobalData
Contact Us
Disclaimer
List of Tables
Natera Inc Pipeline Products and Ongoing Clinical Trials Overview
Natera Inc Pipeline Products by Equipment Type
Natera Inc Pipeline Products by Indication
Natera Inc Ongoing Clinical Trials by Trial Status
Natera Inc, Key Facts
Natera Inc, Major Products and Services
Natera Inc Number of Pipeline Products by Development Stage
Natera Inc Pipeline Products Summary by Development Stage
Natera Inc Ongoing Clinical Trials by Trial Status
Natera Inc Ongoing Clinical Trials Summary
Anora Natera Miscarriage POC Test - Product Status
Anora Natera Miscarriage POC Test - Product Description
Constellation - Product Status
Constellation - Product Description
dd-cfDNA Assay - Kidney Transplant Rejection - Product Status
dd-cfDNA Assay - Kidney Transplant Rejection - Product Description
Horizon Carrier Screen Test - Product Status
Horizon Carrier Screen Test - Product Description
Non-Invasive DNA Based Test - Breast Cancer - Product Status
Non-Invasive DNA Based Test - Breast Cancer - Product Description
Non-Invasive DNA Based Test - Lung Cancer - Product Status
Non-Invasive DNA Based Test - Lung Cancer - Product Description
Non-Invasive DNA Based Test - Ovarian Cancer - Product Status
Non-Invasive DNA Based Test - Ovarian Cancer - Product Description
Non-invasive DNA Based Test - Therapeutic Monitoring - Product Status
Non-invasive DNA Based Test - Therapeutic Monitoring - Product Description
Panorama Non-Invasive Prenatal Expanded Test - Product Status
Panorama Non-Invasive Prenatal Expanded Test - Product Description
Panorama Non-Invasive Prenatal Expanded Test - Development of Non-invasive Prenatal Diagnostic Test for Multiple Gestation Pregnancies Based on Fetal DNA Isolated from Maternal Blood
Panorama Non-Invasive Prenatal Expanded Test - Development of Non-invasive Prenatal Diagnostic Test for Multiple Gestation Pregnancies Based on Fetal DNA Isolated from Maternal Blood
Panorama Non-Invasive Prenatal Expanded Test - Development of Non-invasive Prenatal Test for Microdeletion/Duplication and Other Genetic Syndromes Based on Fetal DNA Isolated from Maternal Blood
Panorama Non-Invasive Prenatal Expanded Test - SNP-based Microdeletion and Aneuploidy Registry
Signatera - Breast Cancer - Product Status
Signatera - Breast Cancer - Product Description
Signatera - Colorectal Cancer - Product Status
Signatera - Colorectal Cancer - Product Description
Spectrum PGD Test - Product Status
Spectrum PGD Test - Product Description
Spectrum PGS Test - Product Status
Spectrum PGS Test - Product Description
Vistara Non-Invasive Prenatal Test - Product Status
Vistara Non-Invasive Prenatal Test - Product Description
Vistara Non-Invasive Prenatal Test - Development of Non-invasive Prenatal Diagnostic Test for Multiple Gestation Pregnancies Based on Fetal DNA Isolated from Maternal Blood
Natera Inc, Key Employees
Natera Inc, Subsidiaries
Glossary
List of Figures
Natera Inc Pipeline Products by Equipment Type
Natera Inc Pipeline Products by Development Stage
Natera Inc Ongoing Clinical Trials by Trial Status

Download our eBook: How to Succeed Using Market Research

Learn how to effectively navigate the market research process to help guide your organization on the journey to success.

Download eBook

Share this report